Alessandra Vitelli

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19

A. Folgori, C. Agrati, E. Cimini, 2021, npj Vaccines.

Humoral and cellular immunity to RSV in infants, children and adults.

P. Klenerman, A. Thompson, A. Pollard, 2018, Vaccine.

GRAd-COV2, a gorilla adenovirus based candidate vaccine against COVID-19, is safe and immunogenic in young and older adults

A. Folgori, G. Kroemer, C. Agrati, 2021, medRxiv.

Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance

A. Folgori, R. Cortese, A. Nicosia, 2006, Gut.